Integrated Wealth Concepts LLC Sells 2,850 Shares of Aflac Incorporated (NYSE:AFL)

Integrated Wealth Concepts LLC lowered its holdings in Aflac Incorporated (NYSE:AFL) by 7.3% in the 4th quarter, HoldingsChannel reports. The firm owned 36,383 shares of the financial services provider’s stock after selling 2,850 shares during the quarter. Integrated Wealth Concepts LLC’s holdings in Aflac were worth $3,763,000 as of its most recent SEC filing.

Other hedge funds have also recently modified their holdings of the company. Norges Bank purchased a new position in Aflac during the fourth quarter valued at approximately $349,699,000. Raymond James Financial Inc. bought a new stake in Aflac during the 4th quarter valued at $163,409,000. Amundi increased its holdings in shares of Aflac by 81.1% in the 4th quarter. Amundi now owns 2,753,513 shares of the financial services provider’s stock valued at $285,181,000 after acquiring an additional 1,232,683 shares during the period. Vanguard Group Inc. raised its position in shares of Aflac by 1.3% in the 4th quarter. Vanguard Group Inc. now owns 51,340,298 shares of the financial services provider’s stock worth $5,310,640,000 after acquiring an additional 653,275 shares in the last quarter. Finally, Assenagon Asset Management S.A. lifted its stake in shares of Aflac by 670.9% during the 4th quarter. Assenagon Asset Management S.A. now owns 556,576 shares of the financial services provider’s stock worth $57,572,000 after purchasing an additional 484,378 shares during the last quarter. Hedge funds and other institutional investors own 67.44% of the company’s stock.

Insider Buying and Selling at Aflac

In other Aflac news, Director Joseph L. Moskowitz sold 1,000 shares of the business’s stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $107.63, for a total value of $107,630.00. Following the completion of the transaction, the director now directly owns 25,393 shares of the company’s stock, valued at approximately $2,733,048.59. The trade was a 3.79 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Charles D. Lake II sold 29,802 shares of Aflac stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $107.29, for a total transaction of $3,197,456.58. Following the transaction, the director now directly owns 49,962 shares of the company’s stock, valued at approximately $5,360,422.98. This trade represents a 37.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.90% of the stock is owned by corporate insiders.

Aflac Trading Down 1.1 %

Shares of NYSE:AFL opened at $107.96 on Friday. The business has a 50-day moving average price of $107.14 and a 200-day moving average price of $107.11. The stock has a market cap of $58.93 billion, a price-to-earnings ratio of 11.25, a PEG ratio of 3.24 and a beta of 0.81. Aflac Incorporated has a 52-week low of $80.59 and a 52-week high of $115.50. The company has a quick ratio of 0.08, a current ratio of 0.10 and a debt-to-equity ratio of 0.29.

Aflac (NYSE:AFL) last announced its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $1.56 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. Equities analysts predict that Aflac Incorporated will post 6.88 EPS for the current year.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on AFL shares. StockNews.com upgraded Aflac from a “sell” rating to a “hold” rating in a research note on Friday, February 14th. BMO Capital Markets started coverage on shares of Aflac in a research report on Thursday, January 23rd. They issued a “market perform” rating and a $111.00 price objective on the stock. JPMorgan Chase & Co. boosted their price objective on shares of Aflac from $94.00 to $96.00 and gave the stock a “neutral” rating in a research note on Wednesday, April 2nd. Wells Fargo & Company lowered their target price on shares of Aflac from $104.00 to $102.00 and set an “equal weight” rating for the company in a research note on Wednesday, February 19th. Finally, UBS Group upped their price target on Aflac from $109.00 to $114.00 and gave the stock a “neutral” rating in a research report on Wednesday, April 2nd. Two equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $103.93.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.